Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00940472

Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients (DMMET2)

Randomized, Double-Blind, Efficacy and Safety, Controlled Study, Between DMMET-01 and Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetics Patients.

Sponsor: Laboratorios Silanes S.A. de C.V.

Conditions Diabetes Type 2

Interventions DMMET-01 Metformin Hydrochloride

Updated 5 times since 2017 Last updated: May 17, 2010 Started: Mar 31, 2009 Primary completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00940472, this PHASE2/PHASE3 trial focuses on Diabetes Type 2 and remains completed. Sponsored by Laboratorios Silanes S.A. de C.V., it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laboratorios Silanes S.A. de C.V.

Data source: Laboratorios Silanes S.A. de C.V.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guadalajara, Mexico